Atara Biotherapeutics Submits a Plan for the Issuance of 23.01 Million Ordinary Shares to SEC
2026-11-11 06:03:05
According to CoinMeta, Atara Biotherapeutics has submitted documents to the U.S. Securities and Exchange Commission (SEC), and its sales agreement prospectus covers an issuance plan for up to 23.01 million shares of common stock.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.